Lexpos News

/Lexpos News

Category H: guidance and support for pharmacy owners

Community Pharmacy England is releasing guidance ahead of a webinar to explain Category H, the new Drug Tariff category, to pharmacy owners. We have published a comprehensive guide to the new Category H, explaining how entry to and price-setting arrangements for Category H will operate, as well as the background to these changes. Briefing: Category H FAQs Category H webpage List of products moving [...]

The post Category H: guidance and support for pharmacy owners appeared first on Community Pharmacy England.

By |February 3rd, 2026|Lexpos News|Comments Off on Category H: guidance and support for pharmacy owners

MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)

MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(26)A/06 Date issued: 3 February 2026 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. DMRC reference number: DMRC-38317957 Company name:Syri Limited, T/A SyriMed Medicine Details [...]

The post MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) appeared first on Community Pharmacy England.

By |February 3rd, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)

Pharmacy First myth busting

This article tackles some of the misconceptions around who can provide Pharmacy First consultations and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service [...]

The post Pharmacy First myth busting appeared first on Community Pharmacy England.

By |February 2nd, 2026|Lexpos News|Comments Off on Pharmacy First myth busting

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine [...]

The post MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

By |February 2nd, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)

PQS: Declaration window is open

The declaration window for the Pharmacy Quality Scheme (PQS) 2025/26 is now open. Pharmacy owners can make a claim for a PQS payment up to 11.59pm on Friday 27th February 2026 through the MYS portal. Pharmacy owners must have evidence to demonstrate meeting the gateway criterion and the domains that they have claimed for by the end [...]

The post PQS: Declaration window is open appeared first on Community Pharmacy England.

By |February 2nd, 2026|Lexpos News|Comments Off on PQS: Declaration window is open